3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Triple Negative Breast Neoplasms
1
Nevi and Melanomas
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Melanoma
1
Genetic Predisposition to Disease
1
Disease
1
Interventions
Gemcitabine
9
Carboplatin
8
Paclitaxel
7
Capecitabine
7
Irinotecan
6
pembrolizumab
3
Radiotherapy
3
Oxaliplatin
3
Fluorouracil
3
Filgrastim
3
Cisplatin
3
Bevacizumab
3
etoposide phosphate
2
Surveys and Questionnaires
2
Peripheral Blood Stem Cell Transplantation
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Genetic Testing
2
FAPI-46
2
Etoposide
2
Erlotinib Hydrochloride
2
Docetaxel
2
Cyclophosphamide
2
Amifostine
2
Albumin-Bound Paclitaxel
2
tislelizumab
1
tegafur-gimeracil-oteracil
1
spartalizumab
1
sintilimab
1
erythromycin propionate-N-acetylcysteinate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Unknown Primary
×
Sequence Analysis, RNA
×
Clear all
NCT07366008
2026-01-26
NorCUP
Haukeland University Hospital
Phase NA
Not yet recruiting
350 enrolled